Literature DB >> 9803983

Drugs and the liver. Symposium proceedings. 21-24 April 1998.

.   

Abstract

Mesh：

Year:  1998        PMID： 9803983      PMCID： PMC1874160          DOI： 10.1046/j.1365-2125.2003.0799a.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

1.  The pharmacokinetics of perindopril in patients with liver cirrhosis.

Authors:  M Thiollet; C Funck-Brentano; J D Grangé; M Midavaine; G Resplandy; P Jaillon
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

2.  Influence of liver cirrhosis on sertraline pharmacokinetics.

Authors:  J L Démolis; P Angebaud; J D Grangé; P Coates; C Funck-Brentano; P Jaillon
Journal:  Br J Clin Pharmacol       Date:  1996-09       Impact factor: 4.335

3.  Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients.

Authors:  A Rames; J M Poirier; F LeCoz; M Midavaine; B Lecocq; J D Grange; R Poupon; G Cheymol; P Jaillon
Journal:  Clin Pharmacol Ther       Date:  1990-03       Impact factor: 6.875

4.  Inhibition by omeprazole of proguanil metabolism: mechanism of the interaction in vitro and prediction of in vivo results from the in vitro experiments.

Authors:  C Funck-Brentano; L Becquemont; A Lenevu; A Roux; P Jaillon; P Beaune
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030
  4 in total
  2 in total

1.  Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease.

Authors:  Y Khaliq; K Gallicano; I Seguin; K Fyke; G Carignan; D Bulman; A Badley; D W Cameron
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals.

Authors:  H Bagheri; F Michel; M Lapeyre-Mestre; E Lagier; J P Cambus; P Valdiguié; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.